Rare but serious risks include pancreatitis, gallbladder disease, acute kidney injury (secondary to dehydration from GI effects), and a theoretical thyroid C-cell tumor risk based on rodent data that has not been confirmed in human post-marketing surveillance
"First oral GLP-1 treatment for weight management"
Here is what you need to know
Monitor renal function in patients reporting adverse reactions to Ozempic that could lead to volume depletion, especially during dosage initiation and escalation Severe Gastrointestinal (GI) Adverse Reactions: Use of Ozempic has been associated with GI adverse reactions, sometimes severe
Is Sjgren's Syndrome Serious
Our combination of Sermorelin + GLP-1 therapy is designed to optimize weight loss, enhance recovery, and protect your strength every step of the way